ALKEM LABS LTD FDA Approval ANDA 211177

ANDA 211177

ALKEM LABS LTD

FDA Drug Application

Application #211177

Application Sponsors

ANDA 211177ALKEM LABS LTD

Marketing Status

Prescription001
Prescription002

Application Products

001CAPSULE;ORAL25MG0PREGABALINPREGABALIN
002CAPSULE;ORAL50MG0PREGABALINPREGABALIN

FDA Submissions

UNKNOWN; ORIG1AP2019-09-30STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ALKEM LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211177
            [companyName] => ALKEM LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"PREGABALIN","activeIngredients":"PREGABALIN","strength":"25MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PREGABALIN","activeIngredients":"PREGABALIN","strength":"50MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/30\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-09-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.